Diallo Lab

Optimization of YF17D-Vectored Zika Vaccine Production by Employing Small-Molecule Viral Sensitizers to Enhance Yields

Characterization of Critical Determinants of ACE2–SARS CoV-2 RBD Interaction

First-in-class small molecule potentiators of cancer virotherapy

Combination of Paclitaxel and MG1 oncolytic virus as a successful strategy for breast cancer treatment

Single-particle characterization of oncolytic vaccinia virus by flow virometry

Oncolytic vesicular stomatitis virus expressing interferon-gamma has enhanced therapeutic activity

Clonal variation in interferon response determines the outcome of oncolytic virotherapy in mouse CT26 colon carcinoma model

VEGF-Mediated Induction of PRD1-BF1/Blimp1 Expression Sensitizes Tumor Vasculature to Oncolytic Virus Infection

Microtubule disruption synergizes with oncolytic virotherapy by inhibiting interferon translation and potentiating bystander killing

Reciprocal cellular cross-talk within the tumor microenvironment promotes oncolytic virus activity

High-throughput titration of luciferase-expressing recombinant viruses

Pharmacological modulation of anti-tumor immunity induced by oncolytic viruses